Los Angeles Capital Management LLC Axsome Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$50.63 - $73.5 $251,681 - $365,368	-4,971 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$55.91 - $81.44 $243,152 - $354,182	-4,349 Reduced 46.66%	4,971 $281,000
Q4 2020 Feb 04, 2021	BUY	$66.31 - $86.52 $8,288 - $10,815	125 Added 1.36%	9,320 $759,000
Q2 2020 Aug 05, 2020	BUY	$49.87 - $98.69 $41,392 - $81,912	830 Added 9.92%	9,195 $756,000
Q1 2020 May 04, 2020	BUY	$41.2 - $101.31 $344,638 - $847,458	8,365 New	8,365 $492,000

327

37.8M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.94B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.